Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 Tampilan
• 07/13/23
0
0
Menanamkan
administrator
Pelanggan
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Menampilkan lebih banyak
Komentar Facebook
SORT BY-
Komentar Teratas
-
komentar terbaru